$357.87
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
United Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of United Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-31 | $5.85 | $6.40 | -8.59 % |
Mar 2024 | 2024-05-01 | $6.17 | $5.65 | 9.20 % |
Dec 2023 | 2024-02-21 | $4.36 | $4.19 | 4.06 % |
Sep 2023 | 2023-11-01 | $5.38 | $5.08 | 5.91 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-31 | $714.90M | $691.87M | 3.33 % |
Mar 2024 | 2024-05-01 | $677.70M | $623.97M | 8.61 % |
Dec 2023 | 2024-02-21 | $614.70M | $575.87M | 6.74 % |
Sep 2023 | 2023-11-01 | $609.40M | $587.90M | 3.66 % |
United Therapeutics (UTHR) is scheduled to report earnings on October 30, 2024. The last reported earnings were for reported on July 31, 2024 for Q2.
The Actual EPS was $5.85, which missed the estimate of $6.40.
The Actual Revenue was $714.9M, which beat the estimate of $691.9M.
Browse earnings estimates, EPS, and revenue on all stocks.